Investors
-
Regulatory November 21, 2025 EnglishCorrection: INITIATOR PHARMA: Q3 2025 REPORT
-
Regulatory November 21, 2025 EnglishINITIATOR PHARMA: Q3 2025 REPORT
-
Non Regulatory November 3, 2025 EnglishInitiator Pharma receives UK CTA approval to initiate Phase 2a study in vulvodynia
-
Regulatory November 21, 2025 EnglishCorrection: INITIATOR PHARMA: Q3 2025 REPORT
-
Regulatory November 21, 2025 EnglishINITIATOR PHARMA: Q3 2025 REPORT
-
Regulatory August 22, 2025 EnglishINITIATOR PHARMA: Q2 2025 REPORT
Initiator Pharma Numbers
-
Expected Number of men affected by Erectile Dysfunction worldwide by 2025 322 million
-
Number of women in the US and Europe suffering from Vulvodynia 27 million
-
Men with Erectile Dysfunction who do not respond to drug therapy 40 %